Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma of the Ovary”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT00408967
What this trial is testing

Determine if Either of 2 Doses of Study Drug Given With a Low-dose of Cyclophosphamide After a Complete or Partial Response to a Platinum-based Second-line Therapy in Women With Recurrent Ovarian Carcinoma Results in a Longer Time to Progression When Compared to the First Time to Progression.

Who this might be right for
Ovarian Cancer
EMD Serono
Early research (Phase 1)Ended earlyNCT02452775
What this trial is testing

Autologous OC-L Vaccine and Ovarian Cancer

Who this might be right for
Primary Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Abramson Cancer Center at Penn Medicine 3
Testing effectiveness (Phase 2)Looking for participantsNCT06437353
What this trial is testing

Surufatinib Combined With Carboplatin/Paclitaxel and Surufatinib Combined With Olaparib as First-line and Maintenance Therapy for Newly Diagnosed High-risk Ovarian Cancer

Who this might be right for
Ovarian Cancer
Anhui Provincial Cancer Hospital 74
Testing effectiveness (Phase 2)Study completedNCT00563836
What this trial is testing

Phase II Study of the Trifunctional Antibody Catumaxomab Administered Intra- and Postoperatively in Patients With Ovarian Cancer

Who this might be right for
Ovarian CancerEpithelial Ovarian Cancer
Neovii Biotech 41
Testing effectiveness (Phase 2)Study completedNCT01899599
What this trial is testing

PankoMab-GEX™ Versus Placebo as Maintenance Therapy in Advanced Ovarian Cancer

Who this might be right for
Ovarian Epithelial Cancer RecurrentFallopian Tube CancerPrimary Peritoneal Cancer
Glycotope GmbH 216
Not applicableStudy completedNCT05427214
What this trial is testing

Imaging Study on Halcyon 4.0 System for Patients Receiving Radiation Therapy

Who this might be right for
Brain CancerHead and Neck CancerLung Cancer+3 more
Washington University School of Medicine 52
Large-scale testing (Phase 3)UnknownNCT03220932
What this trial is testing

Cytoreductive Surgery and HIPEC in First or Secondary Platinum-resistant Recurrent Ovarian Epithelial Cancer

Who this might be right for
Ovarian Epithelial Cancer
Hospices Civils de Lyon 132
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06990516
What this trial is testing

SHR - A1811 Injection in the Treatment of Platinum-sensitive Recurrent Ovarian Cancer

Who this might be right for
Ovarian Cancer
Tongji Hospital 90
Not applicableLooking for participantsNCT07280312
What this trial is testing

Ultrasound Microvessel Imaging for the Evaluation of Ovarian and Adnexal Lesions

Who this might be right for
Female Reproductive System Adnexal NeoplasmOvarian CarcinomaFemale Reproductive System Neoplasm+3 more
Mayo Clinic 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT03587311
What this trial is testing

Bevacizumab and Anetumab Ravtansine or Paclitaxel in Treating Patients With Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube Endometrioid AdenocarcinomaFallopian Tube High Grade Serous AdenocarcinomaOvarian Endometrioid Adenocarcinoma+5 more
National Cancer Institute (NCI) 96
Testing effectiveness (Phase 2)Active Not RecruitingNCT03579316
What this trial is testing

Adavosertib With or Without Olaparib in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Recurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma
M.D. Anderson Cancer Center 96
Testing effectiveness (Phase 2)Ended earlyNCT02469116
What this trial is testing

Carboplatin Plus Docetaxel With Day 2 Pegylated G-CSF (Neulasta®) in Patients With Advanced Stage Ovarian Carcinoma

Who this might be right for
Ovarian Cancer
Washington University School of Medicine 18
Not applicableLooking for participantsNCT07125209
What this trial is testing

Cognitive Impact of Neoadjuvant Chemotherapy for Gynecologic Cancers

Who this might be right for
Ovarian CancerCognitive Change
University of Wisconsin, Madison 18
Large-scale testing (Phase 3)Active Not RecruitingNCT02655016
What this trial is testing

Niraparib (GSK3985771) Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy

Who this might be right for
Ovarian Neoplasms
Tesaro, Inc. 733
Early research (Phase 1)Active Not RecruitingNCT04616534
What this trial is testing

Testing the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid Tumors

Who this might be right for
Advanced Fallopian Tube CarcinomaAdvanced Malignant Solid NeoplasmAdvanced Ovarian Carcinoma+19 more
National Cancer Institute (NCI) 14
Early research (Phase 1)Study completedNCT00877253
What this trial is testing

Determine MTD, Evaluate Efficacy and Safety of Genexol®-PM Plus Carboplatin With Advanced Ovarian Cancer

Who this might be right for
Ovarian Cancer
Samyang Biopharmaceuticals Corporation 18
Large-scale testing (Phase 3)Looking for participantsNCT05804370
What this trial is testing

Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)

Who this might be right for
Ovarian Cancer
NX Development Corp 170
Early research (Phase 1)Study completedNCT01248273
What this trial is testing

Unimolecular Pentavalent (Globo-H-GM2-sTn-TF-Tn) Immunization of Patients With Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer in First Remission

Who this might be right for
Fallopian TubesOvarian CancerPeritoneal Cancer
Memorial Sloan Kettering Cancer Center 26
Early research (Phase 1)Study completedNCT02960594
What this trial is testing

HTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse

Who this might be right for
Breast CancerLung CancerPancreatic Cancer+6 more
Inovio Pharmaceuticals 93
Not applicableEnded earlyNCT00003794
What this trial is testing

Quality-of-Life Study of Patients With Previously Treated Ovarian Cancer

Who this might be right for
Ovarian Cancer
Gynecologic Oncology Group
Next Page